Immuno-Oncology Product Solutions
Cell-based products to enable fast, effective, & clinically-relevant understanding & development of immuno-oncology therapeutics.
Obesity and Diabetes Product Solutions
Assays to enable interrogation of the MOA of GLP-1, GIP, and GCG receptors targeting therapeutics to accelerate obesity and type-2 diabetes drug devel...Show More
Assays for Covid-19 Drug Discovery
Cell-based assays to accelerate COVID-19 drug discovery from basic research through QC lot release programs focused on managing proinflammatory cytoki...Show More